Overview

Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

Status:
Recruiting

Trial end date:
2025-06-02

Target enrollment:

Participant gender:

Summary

The investigators aim to address the following specific aims: - Determine the efficacy of Prog/DMPA in preventing postpartum smoking relapse and reducing smoking relapse risk factors. - Examine the effects of this maternal smoking intervention on infant health. - Examine racial and ethnic differences in intervention outcomes.

Phase:

Phase 4

Details

Lead Sponsor:

University of Minnesota

Collaborators:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Arizona

Treatments:

Medroxyprogesterone
Medroxyprogesterone Acetate
Progesterone